My first look at an SGX stock annual report
My first look at a SGX stock’s annual report used to feel like homework. I would catch a headline profit number, then retreat to the price chart. Now I treat the report as a map: where cash came from, what the company owes, and whether profit became funds available to shareholders.
The annual report also slows a fast-moving story. It provides audited numbers, accounting policies, segment details, risks and management’s capital-allocation decisions. That lets me test whether the business I saw in headlines matches the business that appears in the financial statements.
My review follows a fixed sequence: growth and margins, operating cash flow, balance-sheet resilience, returns on capital, and dividends or buybacks. I compare several years rather than one. A single period can be distorted by currency movements, acquisitions, working-capital swings or one-off disposals.
I do this from Australia, so I convert SGD figures into AUD carefully and keep Singapore accounting and tax questions separate from Australian ones. The notes below are personal tracking and commentary, not professional financial advice, and they are not a recommendation to buy or sell any security.
Why I read beyond the headline
When I open the latest annual report of an SGX-listed company I am researching, I start with the independent auditor’s report and financial highlights, then move to the primary statements. I want to know whether the opinion is unmodified, whether any emphasis-of-matter paragraph stands out, and whether the headline figures reconcile with the notes.
I then work through the numbers for three to five years. Revenue growth without margin support may indicate aggressive pricing. Profit growth without operating cash flow may suggest weaker collection or an inventory build-up. I also check whether a comparison period was restated following an acquisition or accounting-policy change.
The narrative sections still matter, but I use them to explain the figures rather than replace them. I note management’s priorities, new segments and major acquisitions, then return to the statements to see whether spending and financing support that story. An IPO prospectus can show the original promise; the annual report shows what survived contact with operations.
Following profit into cash
Revenue is the starting point, not the verdict. I compare reported growth with organic growth, volume or price effects, and segment performance. For a consumer business, rising revenue is more meaningful if gross margin and customer retention hold. I also ask whether the company merely purchased its growth.
Operating profit becomes more useful when I test cash conversion. I subtract cash tax, interest, working-capital changes and capital expenditure to estimate free cash flow. A strong year may hide heavy spending on new capacity, while a weak cash year may reflect a planned inventory build that later supports sales. The notes usually reveal which explanation fits.
Per-share figures stop a growing company from looking healthier than it is. A diluted share count that keeps climbing can absorb the benefit of rising profit, so I track basic and diluted earnings, share-based awards and buybacks together. I also compare dividends with free cash flow and earnings, not just the headline yield. To judge whether growth matters at household scale, I compare consumer-company sales patterns with my household spending log.
Testing the balance sheet
On the balance sheet, I start with cash, borrowings and lease liabilities, then look at receivables, inventory and supplier funding. I calculate net cash or net debt, check debt maturities and interest cover, and ask whether cash is genuinely unrestricted. Strong liquidity can be valuable, but it should not disguise weak operating economics.
Capital allocation is the next test. I ask whether the company earns a sensible return on new plants, technology or acquisitions, and whether growth creates value rather than merely enlarging the business. Buybacks matter only if the company has spare cash and is not reducing its share count while balance-sheet stress builds. Before committing money, I apply similar discipline through my net worth method, including CPF balances that cannot fund an overseas purchase.
Finally, I scan contingent liabilities, legal disputes, related-party transactions, pledges and off-balance-sheet commitments. These notes can reveal obligations that a tidy summary page leaves out. I do not treat every mention as a red flag; I ask whether the amount is material and whether the disclosure explains the exposure clearly.
Reading the disclosures from Australia
Singapore reporting gives me a useful comparison with the ASX. SGX issuers publish audited annual reports under Singapore law and generally present financial statements using Singapore Financial Reporting Standards, which are substantially converged with IFRS. I still read the basis of preparation because presentation choices and segment definitions can change comparability with Australian-listed companies.
For Australian tax residents, foreign dividends and gains may still form part of the annual return, with foreign tax credits generally available for eligible tax paid overseas. The exact result depends on residency, holding structure and personal circumstances. I also remember that franking credits attached to many ASX dividends do not translate automatically to an SGX payout. A broker’s SGX access, AUD/SGD conversion and commission schedule are worth checking before placing an order.
Local habits make the numbers more concrete. A Melbourne or Sydney household may track an offset account, superannuation balance and weekly grocery spending in AUD, while the issuer reports in SGD. Singapore’s compact public transport and high-rise business districts also affect labour and operating costs differently from Australian cities. For a rough check on local healthcare inflation, I revisit my regional clinic price check, while remembering that one service basket is not evidence about a whole issuer.
My two-pass review checklist
The checklist has two passes. The first removes obvious weaknesses; the second asks whether the numbers can support a reasonable investment case.
- Revenue growth: Compare three to five years and separate organic growth from acquisitions.
- Margin direction: Check whether pricing, product mix or input costs explain the trend.
- Cash conversion: Compare operating cash flow with operating profit across the cycle.
- Free cash flow: Normalise capital expenditure before judging distributable cash.
Items that fail the first pass still receive context rather than an instant verdict.
- Net cash or debt: Include lease obligations and upcoming debt maturities.
- Return on capital: Compare returns on reinvestment with the cost of capital.
- Dividend cover: Test the payout against both free cash flow and earnings.
- Share count: Check dilution, employee options and buyback activity.
I record the evidence beside each result, including the page number and note reference. That simple audit trail prevents a strong headline later in the report from quietly overriding an earlier problem.
My metric scorecard and next review
After both passes, I summarise the review in a compact scorecard. It is not designed to produce a mechanical buy signal; it shows whether the business is improving, stable or deteriorating and which assumption my thesis depends on.
| Metric | What I compare | My warning sign |
|---|---|---|
| Revenue and organic growth | Three-to-five-year trend | Growth depends mainly on acquisitions |
| Operating margin | Current year, prior year and peers | Falling margin despite rising volume |
| Operating cash flow | Cash generated versus reported profit | Repeated gap between profit and cash |
| Free cash flow | Normalised after capital expenditure | Little cash remains after sustaining investment |
| Net cash or debt | Cash, borrowings and lease liabilities | Near-term maturities against weak cash flow |
| Return on invested capital | Returns from newly invested capital | More capital but little additional profit |
| Dividend and buyback cover | Payout against cash flow and earnings | Distributions funded through new debt |
| Share count and dilution | Weighted shares, options and buybacks | Persistent dilution for existing investors |
| Audit and contingencies | Opinion, key risks and legal notes | Qualification or unclear material exposure |
The most useful row is usually free cash flow because it connects operating performance with capital allocation. If that row is strong but net debt is rising, I inspect acquisitions and shareholder returns. If profit is strong but cash conversion is weak, I inspect receivables, inventory and contract balances. The rows work as checks on one another, not as separate scores.
The next step is to choose one SGX holding, download its latest audited annual report, and record revenue growth, operating cash flow, free cash flow, net cash and dilution in your own tracker. Revisit those entries when the next audited results arrive, and let the evidence—not a one-day price move—determine whether the thesis still holds.